Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin for Radiation Enteritis in Gynecological Cancer
NCT05138887Phase 2Unknown
- Sponsor
- West China Second University Hospital
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sapropterin in radiation enteritis, sponsored by West China Second University Hospital. Status: unknown.
02
Drugs
sapropterin
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on NCT05138887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138887.